Acquisition brings access to a novel investigational ß-lactamase inhibitor, expanding pipeline of critically needed antimicrobials, and further augments R&D capabilities and expertise OSAKA, Japan, June… Read More
Financing accelerates MT-302, the Company’s first clinical candidate for in vivo cell programming, into a Phase 1/2 clinical trial for TROP2+ solid tumors CAMBRIDGE,… Read More
For Marco B. Zoccali, MD, FACS, a colorectal surgeon at NewYork-Presbyterian/Columbia, sacral nerve stimulation (SNS) has been a routine part of the care he… Read More
Bob was the most giving of people, who always had the time and focus to make you feel like you were his only concern. As… Read More
CHICAGO, Dec. 8, 2022 /PRNewswire/ — Cardiosense, Inc., a Chicago-based digital health company leveraging artificial intelligence and multi-sensor devices to… Read More
Teleflex to Expand Its Surgical Portfolio with Differentiated Stapling Technology for Bariatric Surgery Signs Definitive Agreement to Acquire Standard Bariatrics WAYNE,… Read More
By: Clay Thorp, General Partner, Hatteras Venture Partners Michael Yee of Jefferies is one of the best analysts in biotech, and he knows his… Read More
With the commercialization of Qvella technology for Positive Blood Culture (PBC) processing, healthcare facilities can now get results up to 24 hours faster than current… Read More
Company also secures $9.5 million in Series A funding to expand its resources to meet rapidly growing customer demand PALO ALTO, Calif.–(BUSINESS… Read More
Acquisition Enables Company to Provide More High-Value, Patient-Centered Services Through Its Network of More Than 1,000 Independent Primary Care Practices and Health Centers Bethesda, Md. Read More